Recent Progress on the Development of Antibiotics from the Genus Micromonospora

다국어 초록 (Multilingual Abstract)

The emergence of a large number of antimicrobialresistant organisms is a cause for concern. Nature is historically the source of drugs; indeed a considerable number of drugs have been developed from microorganisms, and are now used daily in the treatment of infectious diseases. However, the introduction to the pharmaceutical market of new therapeutic molecules has decreased during the last two decades. In this review, the genus Micromonospora is proposed as a biofactory for production of new antibiotics. The genus Micromonospora has been investigated extensively and more than 100 antibiotics have been isolated from diverse Micromonospora strains. In addition, recent developments in analytical, biological and bioinformatics screening tools used in the discovery of new therapeutic compounds are described. It may be possible to revive formerly used antibiotics produced by Micromonospora and study of this genus may facilitate discovery of novel bioactive molecules.

참고문헌 (Reference)

• 1 Sugawara, T., "YM-47515, a novel isonitrile antibiotic from Micromonospora echinospora subsp. echinospora" 50 : 944-948, 1997
• 2 World Health Organization, "WHO Model List of Essential Medicines"
• 3 Weinstein, M. J., "Verdamicin, a new broad spectrum aminoglycoside antibiotic" 7 : 246-249, 1975
• 4 Stockwell, V. O, "Use of antibiotics in plant agriculture" 31 : 199-210, 2012
• 5 Chen, C, "Update on new medicinal applications of gentamicin: Evidence-based review" 113 : 72-82, 2014
• 6 Agence francaise de securite sanitaire des produits de sante, "Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring" 42 : 301-308, 2012
• 7 Bonitz, T., "Unusual Nprenylation in diazepinomicin biosynthesis: The Farnesylation of a benzodiazepine substrate is catalyzed by a new member of the ABBA prenyltransferase superfamily" 8 : e85707-, 2013
• 8 Fang, B. Z., "Two new species of the genus Micromonospora: Micromonospora palomenae sp. nov. and Micromonospora harpali sp. nov. isolated from the insects" 108 : 141-150, 2015
• 9 Ando, O, "Trehazolin, a new trehalase inhibitor" 44 : 1165-1168, 1991
• 10 Tatsuta, K., "Total synthesis of MS-444, a myosin light chain kinase inhibitor" 50 : 289-290, 1997
• 11 Sang, F., "Total synthesis and determination of the absolute configuration of Rakicidin A" 136 : 15787-15791, 2014
• 12 Boger, D. L., "Total syntheses of thiocoraline and BE-22179: Establishment of relative and absolute stereochemistry" 122 : 2956-2957, 2000
• 13 Boger, D. L., "Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological properties" 123 : 561-568, 2001
• 14 Bérdy, J., "Thoughts and facts about antibiotics: Where we are now and where we are heading" 65 : 385-395, 2012
• 15 Just-Baringo, X., "Thiopeptide antibiotics: Retrospective and recent advances" 12 : 317-351, 2014
• 16 Bagley, M. C, "Thiopeptide antibiotics" 105 : 685-714, 2005
• 17 Zamudio-Vaazquez, R., "Thioester bonds of thiocoraline can be replaced with nme-amide bridges without affecting its dna-binding properties" 5 : 45-50, 2014
• 18 Baz, J. P., "Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora .2. Physico-chemical properties and structure determination" 50 : 738-741, 1997
• 19 Erba, E., "Thiocoraline, a novel DNA polymerase inhibitor with a higher cytotoxic potency against cancer cells with mutated or inactivated p53" 9 : 141-141, 1998
• 20 Romero, F, "Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora .1. Taxonomy, fermentation, isolation, and biological activities" 50 : 734-737, 1997
• 21 Wyche, T. P, "Thiocoraline activates transcription of notch and inhibits the proliferation of carcinoid tumor cells" 78 : 1150-1151, 2012
• 22 Wyche, T. P., "Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo" 21 : 518-525, 2014
• 23 Qin, C., "Therapeutic target database update 2014: A resource for targeted therapeutics" 42 : D1118-D1123, 2014
• 24 Cox, D. G., "The utility of metabolomics in natural product and biomarker characterization" 1840 : 3460-3474, 2014
• 25 Iida, T, "The structures of fortimicins C, D, and KE" 32 : 1273-1279, 1979
• 26 Sheehan, J. C, "The structure of telomycin" 90 : 462-470, 1968
• 27 Daniels, P. J, "The structure of antibiotic G-52, a new aminocyclitolaminoglycoside antibiotic produced by Micromonospora zionensis" 29 : 488-491, 1976
• 28 Harvey, A. L, "The reemergence of natural products for drug discovery in the genomics era" 14 : 111-129, 2015
• 29 Jaret, R. S, "The megalomicins. V. Mass spectral studies" 13 : 1389-1400, 1973
• 30 Jaret, R. S., "The megalomicins. IV. The structures of megalomicins A, B, C1, and C2" 13 : 1374-1388, 1973
• 31 Mallams, A. K., "The megalomicins. II. The structure of megalomicin A" 91 : 7506-7508, 1969
• 32 Mallams, A. K, "The megalomicins. I. D-rhodosamine, a new dimethylamino sugar" 91 : 7505-7506, 1969
• 33 Mallams, A. K, "The megalomicins. 3. D-Rhodosamine, a new dimethylamino-sugar" 13 : 1369-1374, 1973
• 34 Marquez, J. A., "The hazimicins, a new class of antibiotics. Taxonomy, fermentation, isolation, characterization and biological properties" 36 : 1101-1108, 1983
• 35 Dierig, A., "The fast route to microbe identification matrix assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS)" 34 : 97-99, 2015
• 36 Rees, W. D., "The expression of Escherichia-coli threonine synthase and the production of threonine from homoserine in mouse 3t3 cells" 291 : 315-322, 1993
• 37 Colis, L. C., "The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA" 6 : 504-510, 2014
• 38 Trujillo, M. E., "The Prokaryotes - Actinobacteria" Springer-Verlag 499-569, 2014
• 39 Abou-Zeid, A. A, "The Fermentative Production of Gentamicins by Micromonospora purpurea" 24 : 655-662, 1974
• 40 Tamaoki, T., "Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity" 33 : 946-950, 1980
• 41 Tomita, F, "Tetrocarcins, novel antitumor antibiotics. I. Producing organism, fermentation and antimicrobial activity" 33 : 940-945, 1980
• 42 Morimoto, M., "Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A" 35 : 1033-1037, 1982
• 43 Tamaoki, T, "Tetrocarcins E1, E2, F and F-1, new antibiotics. Fermentation, isolation and characterization" 35 : 979-984, 1982
• 44 Misiek, M., "Telomycin, a new antibiotic" 5 : 852-855, 1957
• 45 Donadio, S., "Targets and assays for discovering novel antibacterial agents" 99 : 175-186, 2002
• 46 Banskota, A. H, "TLN-05220, TLN-05223, new Echinosporamicin-type antibiotics, and proposed revision of the structure of bravomicins" 62 : 565-570, 2009
• 47 Falagas, M. E, "Susceptibility of Gram-negative bacteria to isepamicin: A systematic review" 10 : 207-218, 2012
• 48 Li, S. Y., "Substrate recognition by the multifunctional cytochrome P450MycG in mycinamicin hydroxylation and epoxidation reactions" 287 : 37880-37890, 2012
• 49 Erikson, D, "Studies on some Lake-Mud strains of Micromonospora" 41 : 277-300, 1941
• 50 Choi, D., "Studies on production of gentamicin from Micromonosporas purpurea using crude vegetable oils" 43 : 835-841, 2008
• 51 Kishi, T, "Studies on juvenimicin, a new antibiotic. II. Isolation, chemical characterization and structures" 29 : 1171-1181, 1976
• 52 Hatano, K., "Studies on juvenimicin, a new antibiotic. I. Taxonomy, fermentation and antimicrobial properties" 29 : 1163-1170, 1976
• 53 Nishizawa, N, "Studies on a new nucleoside antibiotic, dapiramicin. II. Isolation, physico-chemical and biological characterization" 37 : 1-5, 1984
• 54 Shomura, T, "Studies on a new nucleoside antibiotic, dapiramicin. I. Producing organism, assay method and fermentation" 36 : 1300-1304, 1983
• 55 Tani, K, "Studies on a new antibiotic M-92 produced by Micromonospora. III. Biological activities" 35 : 1441-1447, 1982
• 56 Tani, K, "Studies on a new antibiotic M-92 produced by Micromonospora. II. Isolation and physicochemical properties of M-92 and its components" 35 : 1437-1440, 1982
• 57 Tani, K., "Studies on a new antibiotic M-92 produced by Micromonospora. I. Taxonomy of M-92 producing Micromonospora and antibiotic production therefrom" 35 : 1430-1436, 1982
• 58 Ganguly, A. K, "Structures of halomicins A and C" 30 : 625-627, 1977
• 59 Yang, S. W., "Structure elucidation of a new diketopiperazine Sch 725418from Micromonospora sp. J. Antibiot" 57 : 345-347, 2004
• 60 Aotani, Y., "Structure determination of Ms-444 - a new myosin light-chain kinase inhibitor" 48 : 952-953, 1995
• 61 Guo, J., "Specificity and promiscuity at the branch point in gentamicin biosynthesis" 21 : 608-618, 2014
• 62 Tulla-Puche, J, "Solidphase synthesis of oxathiocoraline by a key intermolecular disulfide dimer" 129 : 5322-5323, 2007
• 63 Itoh, J, "Sibanomicin, a new pyrrolo[1,4]benzodiazepine antitumor antibiotic produced by a Micromonospora sp" 41 : 1281-1284, 1988
• 64 Qiu, D. H., "Selective isolation and rapid identification of members of the genus Micromonospora" 74 : 5593-5597, 2008
• 65 Krug, D, "Secondary metabolomics: The impact of mass spectrometry-based approaches on the discovery and characterization of microbial natural products" 31 : 768-783, 2014
• 66 Puar, M. S., "Sch 40832:A novel thiostrepton from Micromonospora carbonacea" 51 : 221-224, 1998
• 67 Cooper, R., "Sch 37137, a novel antifungal compound produced by a Micromonospora sp. Taxonomy, fermentation, isolation, structure and biological properties" 41 : 13-19, 1988
• 68 Houge-Frydrych, C. S. V., "SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp. II. Structure determination" 53 : 351-356, 2000
• 69 Stefanska, A. L, "SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp I. Fermentation, isolation and properties" 53 : 345-350, 2000
• 70 Mandala, S. M., "Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase" 273 : 14942-14949, 1998
• 71 Nakayama, H., "Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus" 51 : 853-859, 1987
• 72 Takatsu, T., "Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus" 38 : 1806-1809, 1985
• 73 Crowe, C. C, "Rosamicin: Evaluation in vitro and comparison with erythromycin and lincomycin. Antimicrob" 5 : 272-275, 1974
• 74 Huang, H. Q, "Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica" 95 : 143-148, 2009
• 75 Theuretzbacher, U., "Reviving old antibiotics" 70 : 2177-2181, 2015
• 76 Igarashi, Y, "Revision of the structure assigned to the antibiotic BU-4664L from Micromonopora" 58 : 350-352, 2005
• 77 Stroch, K, "Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. Tu 6368 - II. Structure elucidation" 58 : 103-110, 2005
• 78 Antal, N, "Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. Tu 6368 - I. Taxonomy, fermentation, isolation and biological activities" 58 : 95-102, 2005
• 79 Vieweg, L., "Recent advances in the field of bioactive tetronates" 31 : 1554-1584, 2014
• 80 Hsu, C. C., "Real-time metabolomics on living microorganisms using ambient electrospray ionization flow-probe" 85 : 7014-7018, 2013
• 81 Tiwari, K., "Rare actinomycetes: A potential storehouse for novel antibiotics" 32 : 108-132, 2012
• 82 McBrien, K. D., "Rakicidins, new cytotoxic lipopeptides from Micromonospora sp. Fermentation, isolation and characterization" 48 : 1446-1452, 1995
• 83 Yamazaki, Y., "Rakicidin A:A hypoxia-selective cytotoxin" 30 : 261-265, 2007
• 84 Takeuchi, M., "Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells" 102 : 591-596, 2011
• 85 Laakso, J. A., "R176502, a new bafilolide metabolite with potent antiproliferative activity from a novel Micromonospora species" 56 : 909-916, 2003
• 86 Hayakawa, Y., "Quinolidomicins a(1), a(2) and B(1), novel 60-membered macrolide antibiotics .2. Structure elucidation" 46 : 1563-1569, 1993
• 87 Schroeder, D. R, "Pyrrolosporin A, a new antitumor antibiotic from Micromonospora sp. C39217-R109-7 .2. Isolation, physico-chemical properties, spectroscopic study and X-ray analysis" 49 : 865-872, 1996
• 88 Lam, K. S, "Pyrrolosporin A, a new antitumor antibiotic from Micromonospora sp. C39217-R109-7 .1. Taxonomy of producing organism, fermentation and biological activity" 49 : 860-864, 1996
• 89 Walsh, C. T., "Prospects for new antibiotics: A molecule-centered perspective" 67 : 7-22, 2013
• 90 Anzai, Y., "Production of rosamicin derivatives in Micromonospora rosaria by introduction of D-mycinose biosynthetic gene with PhiC31-derived integration vector pSET152" 36 : 1013-1021, 2009
• 91 Weinstein, M. J, "Process for producing rifamycin sv. US Patent 3,901,764"
• 92 Tann, C. H., "Process for preparing isepamicin. US Patent 5,442,047"
• 93 Reisman, H. B., "Problems in scale-up of biotechnology production processes" 13 : 195-253, 1993
• 94 Hinman, L. M, "Preparation and characterization of monoclonal antibody conjugates of the calicheamicins:A novel and potent family of antitumor antibiotics" 53 : 3336-3342, 1993
• 95 Carlson, S., "Potential chemopreventive activity of a new macrolide antibiotic from a Marine-Derived Micromonospora sp" 11 : 1152-1161, 2013
• 96 Manivasagan, P., "Pharmaceutically active secondary metabolites of marine actinobacteria" 169 : 262-278, 2014
• 97 Avan, I., "Peptidomimetics via modifications of amino acids and peptide bonds" 43 : 3575-3594, 2014
• 98 Janin, Y. L, "Peptides with anticancer use or potential" 25 : 1-40, 2003
• 99 Bayo-Puxan, N., "Oxathiocoraline:Lessons to be learned from the synthesis of complex N-methylated depsipeptides" 2957-2974, 2009
• 100 Raju, C. A. I., "Optimization of media composition for the production of gentamycin by Micromonospora echinospora MTCC 708 using response surface methodology" 2 : 1267-1273, 2012
• 101 Himabindu, M., "Optimization of critical medium components for the maximal production of gentamicin by Micromonospora echinospora ATCC 15838 using response surface methodology" 134 : 143-154, 2006
• 102 Chu, J., "On-line ultrasound stimulates the secretion and production of gentamicin by Micromonospora echinospora" 35 : 569-572, 2000
• 103 Tomita, F., "Novel antitumor antibiotics, tetrocarcins" 33 : 668-670, 1980
• 104 Puar, M. S, "Novel Macrolides from Micromonospora rosaria" 43 : 1497-1501, 1990
• 105 Hayakawa, Y, "Novel 60-membered macrolide antibiotics .1. Taxonomy, fermentation, isolation, physicochemical properties and biological-activity" 46 : 1557-1562, 1993
• 106 Sadarangani, S. P, "Non-anti-infective effects of antimicrobials and their clinical applications: A Review" 90 : 109-127, 2015
• 107 Fosso, M. Y., "New trends in the use of aminoglycosides" 5 : 1075-1091, 2014
• 108 Foulerton, A. G. R., "New species of Streptothrix isolated from the air" 1199-1200, 1905
• 109 Hayakawa, M., "New methods for the highly selective isolation of Micromonospora and Microbispora from soil" 72 : 320-326, 1991
• 110 Kawahara, T., "New hydroxamate metabolite, MBJ-0003, from Micromonospora sp. 29867" 67 : 261-263, 2014
• 111 Shiomi, K., "New antibiotic produced by Micromonospora globosa" 43 : 1000-1005, 1990
• 112 Lam, K. S., "New antibiotic bravomicins for treating various bacterial diseases, prepared using Micromonospora polytrota. US Patent 5,994,543"
• 113 Nara, T., "New antibiotic XK-62-2 (sagamicin). II Taxonomy of the producing organism, fermentative production and characterization of sagamicin" 28 : 21-28, 1975
• 114 Dozzo, P., "New aminoglycoside antibiotics" 20 : 1321-1341, 2010
• 115 Wagman, G. H., "Neomycin production by Micromonospora species 69-683" 26 : 732-736, 1973
• 116 Sato, S., "Neomacquarimicin:A new macquarimicin analog from marine-derived actinomycete" 67 : 479-482, 2014
• 117 Yokoi, T., "Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. III. Structure-activity relationships" 41 : 494-501, 1988
• 118 Yang, L. M, "Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. II. Structural determination and total synthesis" 41 : 488-493, 1988
• 119 Wu, R. Y, "Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. I. The producing organism, fermentation, isolation and biological properties" 41 : 481-487, 1988
• 120 Kopcakova, A., "Need for database extension for reliable identification of bacteria from extreme environments using MALDI TOF mass spectrometry" 68 : 1435-1442, 2014
• 121 Igarashi, Y., "NMR analysis of quinocycline antibiotics: Structure determination of kosinostatin, an antitumor substance from Micromonospora sp. TP-A0468" 55 : 134-140, 2002
• 122 Loke, J., "Mylotarg has potent anti-leukaemic effect: A systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia" 94 : 361-373, 2014
• 123 Sorokin, P., "Mylotarg approved for patients with CD33+acute myeloid leukemia" 4 : 279-280, 2000
• 124 Kinoshita, K, "Mycinamicins, new macrolide antibiotics. XIII. Isolation and structures of novel fermentation products from Micromonospora griseorubida (FERM BP-705)" 45 : 1-9, 1992
• 125 Kinoshita, K., "Mycinamicins, new macrolide antibiotics. XI. Isolation and structure elucidation of a key intermediate in the biosynthesis of the mycinamicins, mycinamicin VIII" 42 : 1869-1872, 1989
• 126 Kinoshita, K., "Mycinamicins, new macrolide antibiotics. X. X-ray crystallography and the absolute configuration of mycinamicin IV" 42 : 1003-1005, 1989
• 127 Kinoshita, K., "Mycinamicins, new macrolide antibiotics. VIII. Chemical degradation and absolute configuration of mycinamicins" 38 : 522-526, 1985
• 128 Hayashi, M., "Mycinamicins, new macrolide antibiotics. VII. Structures of minor components, mycinamicin VI and VII" 36 : 175-178, 1983
• 129 Hayashi, M., "Mycinamicins, new macrolide antibiotics. VI. X-ray crystallography of mycinolide IV" 35 : 1243-1244, 1982
• 130 Hayashi, M., "Mycinamicins, new macrolide antibiotics. V. Isolation and structures of new 16-membered aglycones, mycinolide IV and protomycinolide IV" 34 : 1075-1077, 1981
• 131 Harada, K., "Mycinamicins, new macrolide antibiotics. IX. Chemical ionization mass spectral studies on mycinamicins" 38 : 868-876, 1985
• 132 Hayashi, M, "Mycinamicins, new macrolide antibiotics. IV. Structure of mycinamicin III" 34 : 276-281, 1981
• 133 Hayashi, M., "Mycinamicins, new macrolide antibiotics. III Isolation and structures of mycinamicin aglycones, mycinolide IV and V" 34 : 346-349, 1981
• 134 Satoi, S., "Mycinamicins, new macrolide antibiotics. I. Taxonomy, production, isolation, characterization and properties" 33 : 364-376, 1980
• 135 Kinoshita, K., "Mycinamicins, new macrolide antibiotics .12. Isolation and structural elucidation of Mycinamicin-X and Mycinamicin-Xi" 44 : 1270-1273, 1991
• 136 Kinoshita, K, "Mycinamicins, New Macrolide Antibiotics .13. Isolation and structures of novel fermentation products from Micromonospora griseorubida (Ferm Bp-705)" 45 : 1-9, 1992
• 137 Testa, R. T., "Mutamicins; biosynthetically created new sisomicin analogues" 27 : 917-921, 1974
• 138 Nakanishi, S., "Ms-444, a new inhibitor of myosin light-chain kinase from Micromonospora sp. Ky7123" 48 : 948-951, 1995
• 139 Jana, S, "Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance" 6 : 353-361, 2005
• 140 Erba, E., "Mode of action of thiocoraline, a natural marine compound with anti–tumour activity" 80 : 971-980, 1999
• 141 Peric-Concha, N., "Mining the microbial metabolome: A new frontier for natural product lead discovery" 8 : 1078-1084, 2003
• 142 Waksman, S. A., "Micromonosporin, an Antibiotic Substance from a Little-known Group of Microorganisms" 53 : 355-357, 1947
• 143 Thawai, C., "Micromonosporin A, a novel 24-membered polyene lactam macrolide from Micromonospora sp. isolated from peat swamp forest" 1 : 640-645, 2004
• 144 Zhang, L., "Micromonospora zhanjiangensis sp. nov., isolated from mangrove forest" 65 : 4880-4885, 2015
• 145 Shen, Y., "Micromonospora zeae sp. nov., a novel endophytic actinomycete isolated from corn root (Zea mays L.)" 67 : 739-743, 2014
• 146 Jia, F. Y, "Micromonospora vulcania sp nov., isolated from volcanic sediment" 108 : 1383-1390, 2015
• 147 Zhang, Y. J., "Micromonospora violae sp nov., isolated from a root of Viola philippica Car" 106 : 219-225, 2014
• 148 Zhao, J. W, "Micromonospora taraxaci sp. nov., a novel endophytic actinomycete isolated from dandelion root (Taraxacum mongolicum Hand.-Mazz.)" 106 : 667-674, 2014
• 149 Supong, K., "Micromonospora spongicola sp. nov., an actinomycete isolated from a marine sponge in the Gulf of Thailand" 66 : 505-509, 2013
• 150 Gurovic, M. S. V., "Micromonospora schwarzwaldensis sp. nov., a producer of telomycin, isolated from soil" 63 : 3812-3817, 2013
• 151 Xiang, W. S., "Micromonospora polyrhachis sp. nov., an actinomycete isolated from edible Chinese black ant (Polyrhachis vicina Roger)" 64 : 495-500, 2014
• 152 Kittiwongwattana, C., "Micromonospora oryzae sp. nov., isolated from roots of upland rice" 65 : 3818-3823, 2015
• 153 Lin, Y. B., "Micromonospora nickelidurans sp. nov., isolated from nickel mining soil" 65 : 4615-4620, 2015
• 154 Li, C., "Micromonospora maoerensis sp. nov., isolated from a Chinese pine forest soil" 105 : 451-459, 2014
• 155 Gao, R. X, "Micromonospora jinlongensis sp. nov., isolated from muddy soil in China and emended description of the genus Micromonospora" 105 : 307-315, 2014
• 156 Carro, L, "Micromonospora is a normal occupant of actinorhizal nodules" 38 : 685-693, 2013
• 157 Phongsopitanun, W., "Micromonospora fluostatini sp. nov., isolated from marine sediment in Thailand" 65 : 4417-4423, 2015
• 158 Thanaboripat, D., "Micromonospora endophytica sp. nov., an endophytic actinobacteria of Thai upland rice (Oryza sativa)" 68 : 680-684, 2015
• 159 Sanders, W. E., Jr., "Microbiological characterization of everninomicins B and D" 6 : 232-238, 1974
• 160 Donadio, S., "Microbial technologies for the discovery of novel bioactive metabolites" 99 : 187-198, 2002
• 161 Hou, Y., "Microbial strain prioritization using metabolomics tools for the discovery of natural products" 84 : 4277-4283, 2012
• 162 Aldridge, B. B., "Microbial metabolomics:Innovation, application, insight" 19 : 90-96, 2014
• 163 Shafiee, A., "Microbial hydroxylation of rustmicin (galbonolide A) and galbonolide B, two antifungal products produced by Micromonospora sp" 11 : 237-242, 2001
• 164 Demain, A. L, "Microbial drug discovery:80 years of progress" 62 : 5-16, 2009
• 165 Prakash, O, "Microbial cultivation and the role of microbial resource centers in the omics era" 97 : 51-62, 2012
• 166 Kumar, C. G, "Microbial biosynthesis and applications of gentamicin: A critical appraisal" 28 : 173-212, 2008
• 167 Grote, J., "Methodology for the rapid separation of gentamicin components and regiospecific synthesis of gentamicin conjugates" 53 : 6751-6754, 2012
• 168 Li, X., "Metagenomics-based drug discovery and marine microbial diversity" 23 : 539-543, 2005
• 169 Charlop-Powers, Z., "Metagenomic small molecule discovery methods" 19 : 70-75, 2014
• 170 Lee, S. Y, "Metabolic engineering of microorganisms : General strategies and drug production" 14 : 78-88, 2009
• 171 Li, B., "Mass spectrometric characterization of gentamicin components separated by the new European Pharmacopoeia method" 55 : 78-84, 2011
• 172 Blunt, J. W., "Marine natural products" 25 : 35-94, 2008
• 173 Blunt, J. W, "Marine natural products" 33 : 382-431, 2016
• 174 Charney, W, "Manufacture of gentamycin. US Patent 3,136,704"
• 175 Igarashi, Y., "Maklamicin, an antibacterial polyketide from an endophytic Micromonospora sp" 74 : 670-674, 2011
• 176 Hochlowski, J. E, "Macquarimicins, microbial metabolites from Micromonospora. 2. Isolation and structural elucidation" 48 : 467-470, 1995
• 177 Jackson, M., "Macquarimicins, microbial metabolites from Micromonospora .1. Discovery, taxonomy, fermentation and biological properties" 48 : 462-466, 1995
• 178 Vater, J., "MALDITOF mass spectrometry, an efficient technique for in situ detection and characterization of actinomycins" 49 : 210-222, 2014
• 179 Igarashi, Y., "Lupinacidin C, an inhibitor of tumor cell invasion from Micromonospora lupini" 74 : 862-865, 2011
• 180 He, H. Y, "Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis" 123 : 5362-5363, 2001
• 181 Euzeby, J. P., "List of bacterial names with standing in nomenclature: A folder available on the Internet" 47 : 590-592, 1997
• 182 Tidmarsh, G. F, "La Jolla pharmaceutical company acquires rights to next-generation gentamicin derivatives"
• 183 Maiese, W. M., "LL-E19085 alpha, a novel antibiotic from Micromonospora citrea : taxonomy, fermentation and biological activity" 42 : 846-851, 1989
• 184 Furumai, T., "Kosinostatin, a quinocycline antibiotic with antitumor activity from Micromonospora sp. TP-A0468" 55 : 128-133, 2002
• 185 Lam, K. S., "Korkormicins, novel depsipeptide antitumor antibiotics from Micromonospora sp. C39500 - Fermentation, precursor directed biosynthesis and biological-activities" 15 : 60-65, 1995
• 186 Matsuda, Y, "K-259-2, a new inhibitor of Ca2+ and calmodulin-dependent cyclic nucleotide phosphodiesterase from Micromonospora olivasterospora" 40 : 1092-1100, 1987
• 187 Yasuzawa, T., "K-13, a novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia. II. Structure determination" 40 : 455-458, 1987
• 188 Kase, H, "K-13, a novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia. I. Fermentation, isolation and biological properties" 40 : 450-454, 1987
• 189 Bush, K., "Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. II. Biological properties" 33 : 1262-1269, 1980
• 190 Liu, W. C, "Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. I. Detection, isolation and characterization" 33 : 1256-1261, 1980
• 191 Kim, B. S, "Isolation, antifungal activity, and structure elucidation of the glutarimide antibiotic, streptimidone, produced by Micromonospora coerulea" 47 : 3372-3380, 1999
• 192 Ando, O., "Isolation of trehalamine, the aglycon of trehazolin, from microbial broths and characterization of trehazolin related compounds" 46 : 1116-1125, 1993
• 193 Wang, H. S., "Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis" 65 : 721-724, 2002
• 194 Shoji, J., "Isolation of N-(2,6-diamino-6-hydroxymethylpimelyl)-L-alanine from Micromonospora chalcea" 34 : 374-380, 1981
• 195 Woo, C. M., "Isolation of Lomaiviticins C-E, transformation of Lomaiviticin C to Lomaiviticin A, complete structure elucidation of Lomaiviticin A, and structure-activity analyses" 134 : 15285-15288, 2012
• 196 Shoji, J, "Isolation of L-2-(1-methylcyclopropyl)glycine from Micromonospora miyakonensis sp. nov. II. Isolation and characterization" 34 : 370-373, 1981
• 197 Kawamura, Y., "Isolation of L-2-(1-methylcyclopropyl)glycine from Micromonospora miyakonensis sp. nov. I. Taxonomic studies on the producing microorganism" 34 : 367-373, 1981
• 198 Ling, D, "Isolation and structure determination of crisamicin A, a new antibiotic from Micromonospora purpureochromogenes subsp. halotolerans" 39 : 345-353, 1986
• 199 Salauze, D., "Isolation and characterisation of an aminoglycoside phosphotransferase from neomycin-producing Micromonospora chalcea; comparison with that of Streptomyces fradiae and other producers of 4,6-disubstituted 2-deoxystreptamine antibiotics" 44 : 1432-1443, 1991
• 200 Jones, R. N., "Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): Microbiological characteristics including antimicrobial potency of spectrum of activity" 7 : 7-16, 1995
• 201 Ørskov, J., "Investigations into the morphology of the ray fungi" Levin and Munksgaard 1923
• 202 Mantoku, A, "Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins" 34 : 1347-1350, 1981
• 203 de Castro, A. P., "Insights into novel antimicrobial compounds and antibiotic resistance genes from soil metagenomes" 5 : 489-, 2014
• 204 Schmieder, R, "Insights into antibiotic resistance through metagenomic approaches" 7 : 73-89, 2012
• 205 Bush, K, "Inhibition of Escherichia coli TEM-2 beta-lactamase by the sulfated compounds izumenolide, panosialin and sodium dodecyl sulfate" 33 : 1560-1562, 1980
• 206 Zhang, D. -L., "Influence of dissolved oxygen and phosphate on the synthesis and secretion of gentamicin" 28 : 145-147, 2002
• 207 Wang, Y., "Industrial bioprocess control and optimization in the context of systems biotechnology" 27 : 989-995, 2009
• 208 Olsen, S. C., "In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp" 45 : 76-78, 2015
• 209 Marone, P., "In vitro activity of sagamicin against ocular bacterial isolates" 216 : 133-138, 2002
• 210 Santoro, J., "In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole" 10 : 188-190, 1976
• 211 Jones, R. N, "In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: A multicentre international trial" 47 : 15-25, 2001
• 212 Olano, C., "Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering" 10 : 281-292, 2008
• 213 Skellam, E. J, "Identification of micromonolactam, a new polyene macrocyclic lactam from two marine Micromonospora strains using chemical and molecular methods: Clarification of the biosynthetic pathway from a glutamate starter unit" 66 : 431-441, 2013
• 214 Hong, W. R., "Identification of gntK, a gene required for the methylation of purpurosamine C-6 ' in gentamicin biosynthesis" 58 : 349-356, 2012
• 215 Meisner, N. C, "Identification and mechanistic characterization of lowmolecular-weight inhibitors for HuR" 3 : 508-515, 2007
• 216 Song, H. G., "Identification and characterization of a methionine gamma-Lyase in the calicheamicin biosynthetic cluster of Micromonospora echinospora" 16 : 100-109, 2015
• 217 Canedo, L. M, "IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora - II. Physico-chemical properties and structure determination" 53 : 479-483, 2000
• 218 Fernandez-Chimeno, R. I., "IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora - I. Taxonomy, fermentation, isolation and biological activities" 53 : 474-478, 2000
• 219 Cochrane, R. V. K, "Highly selective but multifunctional oxygenases in secondary metabolism" 47 : 3148-3161, 2014
• 220 Fuhrer, T., "High-throughput discovery metabolomics" 31 : 73-78, 2015
• 221 de Rond, T., "High throughput screening of enzyme activity with mass spectrometry imaging" 31 : 1-9, 2015
• 222 Weinstein, M. J., "Halomicin, a new Micromonospora-produced antibiotic" 7 : 435-441, 1967
• 223 Charlop-Powers, Z., "Global biogeographic sampling of bacterial secondary metabolism" 4 : e05048-, 2015
• 224 Luedemann, G. M, "Gentamycin and method of production. US Patent 3,091,572"
• 225 Weinstein, M. J., "Gentamicin,1 a new antibiotic complex from Micromonospora" 6 : 463-464, 1963
• 226 Gonzalez, R., "Gentamicin in Micromonospora purpurea:Stimilatory effect of ammonium" 48 : 479-484, 1994
• 227 Ni, X, "Genetic engineering combined with random mutagenesis to enhance G418 production in Micromonospora echinospora" 41 : 1383-1390, 2014
• 228 Unwin, J., "Gene cluster in Micromonospora echinospora ATCC15835 for the biosynthesis of the gentamicin C complex" 57 : 436-445, 2004
• 229 Iizaka, Y., "Function of cytochrome P450 enzymes RosC and RosD in the biosynthesis of rosamicin macrolide antibiotic produced by Micromonospora rosaria" 57 : 1529-1531, 2013
• 230 Anzai, Y., "Function of cytochrome P450 enzymes MycCI and MycG in Micromonospora griseorubida, a Producer of the macrolide antibiotic mycinamicin" 56 : 3648-3656, 2012
• 231 Sugimoto, M, "Fortimicins C, D and KE, new aminoglycoside antibiotics" 32 : 868-873, 1979
• 232 Girolami, R. L., "Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides" 30 : 564-570, 1977
• 233 Egan, R. S., "Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification" 30 : 552-563, 1977
• 234 Okachi, R., "Fortimicins A and B, new aminoglycoside antibiotics. II. Isolation, physico-chemical and chromatographic properties" 30 : 541-551, 1977
• 235 Nara, T., "Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins" 30 : 533-540, 1977
• 236 Valyi-Nagy, T., "Fermentation of primycin" 20 : 127-140, 1969
• 237 Mousdale, D, "Fermentation microbiology and biotechnology" CRC Press 138-160, 2011
• 238 Chu, J, "Factors affecting the biosynthesis and secretion of gentamicin" 38 : 815-820, 2002
• 239 Jefferson, E., "FDA: Pfizer voluntarily withdraws cancer treatment Mylotarg from U.S. Market"
• 240 Kurtböke, D., "Exploitation of phage battery in the search for bioactive actinomycetes" 89 : 931-937, 2010
• 241 Weinstein, M. J., "Everninomicin, a new antibiotic complex from Micromonospora carbonacea" 10 : 24-32, 1964
• 242 Ratnayake, A. S, "Evaluating indole-related derivatives as precursors in the directed biosynthesis of diazepinomicin analogues" 72 : 496-499, 2009
• 243 Wu, K, "Etimicin sulfate preparation by reacting gentamicin C1a and fluorene methoxycarbonyl chloride, reacting with acetaldehyde, triacetoxy sodium borohydride and piperidine, purifying twice, and reacting with concentrated sulfuric acid"
• 244 Takenaka, S., "Enhancement of mycinamicin production by dotriacolide in Micromonospora griseorubida" 167 : 95-100, 1998
• 245 Shen, B, "Enediynes: Exploration of microbial genomics to discover new anticancer drug leads" 25 : 9-15, 2015
• 246 Fang, J. S., "Emerging mass spectrometry techniques for the direct analysis of microbial colonies" 19 : 120-129, 2014
• 247 Vasoo, S., "Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician" 90 : 395-403, 2015
• 248 Kroppenstedt, R. M., "Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov., Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov" 28 : 328-339, 2005
• 249 Venisse, N., "Efficacy and safety of high-dose gentamicin re-dosing in ICU patients receiving haemodialysis" 70 : 308-310, 2015
• 250 He, H. Y., "Echinosporamicin, a new antibiotic produced by Micromonospora echinospora ssp. echinospora, LL-P175" 87 : 1385-1391, 2004
• 251 Konishi, M, "Dynemicins, New antibiotics with the l, 5-diyn-3-ene and anthraquinone subunit i. Production, isolation and physico-chemical properties" 44 : 6-, 1991
• 252 Konishi, M, "Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit" 42 : 1449-1452, 1989
• 253 Siddique, H, "Drug-resistant infections could lead to 10million extra deaths a year – report"
• 254 Ikeda, Y., "Dotriacolide, a new beta-lactamase inhibitor" 34 : 1628-1630, 1981
• 255 Durante-Mangoni, E., "Do we still need the aminoglycosides?" 33 : 201-205, 2009
• 256 Abdelmohsen, U. R., "Diversity, abundance and natural products of marine sponge-associated actinomycetes" 31 : 381-399, 2014
• 257 Zhao, H. J, "Differentiation of Micromonospora isolates from coastal sediment in wales on the basis of Fourier transform infrared spectroscopy, 16S rRNA sequence analysis, and the amplified fragment length polymorphism technique" 70 : 6619-6627, 2004
• 258 Charan, R. D., "Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp" 67 : 1431-1433, 2004
• 259 Campas, C., "Diazepinomicin Apoptosis Inducer Oncolytic" 34 : 349-351, 2009
• 260 Bassetti, M., "Development of novel antibacterial drugs to combat multiple resistant organisms" 400 : 153-165, 2015
• 261 Vucicevic-Prcetic, K, "Development and validation of liquid chromatography tandem mass spectrometry methods for the determination of gentamicin, lincomycin, and spectinomycin in the presence of their impurities in pharmaceutical formulations" 56 : 736-742, 2011
• 262 Huang, C., "Delineating the biosynthesis of gentamicin x2, the common precursor of the gentamicin C antibiotic complex" 22 : 251-261, 2015
• 263 Lombo, F., "Deciphering the biosynthesis pathway of the antitumor thiocoraline from a marine actinomycete and its expression in two Streptomyces species" 7 : 366-376, 2006
• 264 Kitagaki, J., "DNA intercalator korkormicin A preferentially kills tumor cells expressing wild type p53" 414 : 186-191, 2011
• 265 Stanzak, R., "DNA homology between Saccharopolyspora strains and other erythromycin-producing actinomycetes" 136 : 1899-1904, 1990
• 266 Fehr, T., "Cymbimicin A and B, two novel cyclophilin-binding structures isolated from actinomycetes" 50 : 893-899, 1997
• 267 Kitagaki, J., "Cyclic depsipeptides as potential cancer therapeutics" 26 : 259-271, 2015
• 268 Pichavant, C, "Current status of pharmaceutical and genetic therapeutic approaches to treat DMD" 19 : 830-840, 2011
• 269 Wang, Z. W, "Current methods and advances in microbial metabolomics" 22 : 163-172, 2010
• 270 Subramani, R., "Culturable rare Actinomycetes:diversity, isolation and marine natural product discovery" 97 : 9291-9321, 2013
• 271 Kondo, J., "Crystal structures of a bioactive 6'-hydroxy variant of sisomicin bound to the bacterial and protozoal ribosomal decoding sites" 8 : 733-739, 2013
• 272 Kondo, J, "Crystal structure and specific binding mode of sisomicin to the bacterial ribosomal decoding site" 3 : 741-744, 2012
• 273 Nelson, R. A., "Crisamicin A, a new antibiotic from Micromonospora. I. Taxonomy of the producing strain, fermentation, isolation, physico-chemical characterization and antimicrobial properties" 39 : 335-344, 1986
• 274 Ishigami, K., "Cororubicin, a new anthracycline antibiotic generating active oxygen in tumorcells" 47 : 1219-1225, 1994
• 275 Li, D., "Construction of a gentamicin C1a-overproducing strain of Micromonospora purpurea by inactivation of the gacD gene" 168 : 263-267, 2013
• 276 Ohkuma, H., "Compound produced by a strain of Micromonospora. US Patent 5,541,181"
• 277 Nakanishi, S, "Compound MS-444. WO Patent 1993009109"
• 278 Oku, N., "Complete Stereochemistry and preliminary structure-activity relationship of Rakicidin A, a hypoxia-selective cytotoxin from Micromonospora sp" 77 : 2561-2565, 2014
• 279 Zhanel, G. G., "Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin" 10 : 459-473, 2012
• 280 Yu, P. K., "Comparison of in vitro antibacterial activities of gentamicin and verdamicin" 6 : 526-528, 1974
• 281 Moreau, N., "Comparison of fortimicins with other aminoglycosides and effects on bacterial ribosome and protein synthesis" 26 : 857-862, 1984
• 282 Chaudhary, M., "Comparative antibacterial activity of a novel semisynthetic antibiotic:Etimicin sulphate and other aminoglycosides" 28 : 3365-3371, 2012
• 283 Oka, Y., "Combimicins, new kanamycin derivatives bioconverted by some Micromonosporas" 34 : 777-781, 1981
• 284 Takahashi, Y., "Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. II. Taxonomic study of the producing microorganism" 39 : 1413-1418, 1986
• 285 Omura, S, "Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties" 39 : 1407-1412, 1986
• 286 Carter, G. T, "Citreamicins, novel antibiotics from Micromonospora citrea: Isolation, characterization, and structure determination" 43 : 504-512, 1990
• 287 Herzog, H. L., "Chemistry of antibiotics from Micromonospora. 3. Isolation and characterization of Everninomicin D and B" 13 : 515-520, 1965
• 288 Charlop-Powers, Z., "Chemical-biogeographic survey of secondary metabolism in soil" 111 : 3757-3762, 2014
• 289 Pence, H. E., "ChemSpider: An online chemical information resource" 87 : 1123-1124, 2010
• 290 Hosted, T. J., "Characterization of the biosynthetic gene cluster for the oligosaccharide antibiotic, Evernimicin, in Micromonospora carbonacea var. africana ATCC39149" 27 : 386-392, 2001
• 291 Mady, A. S. A., "Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic cluster" 7 : 1999-2011, 2011
• 292 Sheoran, A., "Characterization of TioF, a tryptophan 2,3-dioxygenase involved in 3-hydroxyquinaldic acid formation during thiocoraline biosynthesis" 4 : 622-628, 2008
• 293 Inouye, M., "Characterization and expression of a P-450-like mycinamicin biosynthesis gene using a novel Micromonospora Escherichia-coli Shuttle Cosmid Vector" 245 : 456-464, 1994
• 294 Salauze, D, "Characterisation of aminoglycoside acetyltransferase-encoding genes of neomycin-producing Micromonospora chalcea and Streptomyces fradiae" 101 : 143-148, 1991
• 295 Venditto, V. J., "Cancer nanomedicines:So many papers and so few drugs! Adv" 65 : 80-88, 2013
• 296 Maiese, W. M, "Calicheamicins, a novel family of antitumor antibiotics: Taxonomy, fermentation and biological properties" 42 : 558-563, 1989
• 297 Lee, M. D., "Calicheamicins, a novel family of antitumor antibiotics. 3. Isolation, purification and characterization of calicheamicins beta 1Br, gamma 1Br, alpha 2I, alpha 3I, beta 1I, gamma 1I and delta 1I" 42 : 1070-1087, 1989
• 298 Lee, M. D, "Calicheamicins - Discovery, Structure, Chemistry, and Interaction with DNA" 24 : 235-243, 1991
• 299 Nguyen Lan Huong, "Biotransformation of Rosamicin Antibiotic into 10,11-Dihydrorosamicin with Enhanced In Vitro Antibacterial Activity Against MRSA" 한국미생물·생명공학회 24 (24): 44-47, 2014
• 300 Wieczner, J., "Biotech pros’ top 8 stock picks"
• 301 Ganguly, A. K, "Biosynthesis of rosamicin" 29 : 976-977, 1976
• 302 McAlpine, J. B., "Biosynthesis of diazepinomicin/ECO-4601, a Micromonospora secondary metabolite with a novel ring system" 71 : 1585-1590, 2008
• 303 Waitz, J. A., "Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic" 25 : 647-652, 1972
• 304 Sévin, D. C, "Biological insights through nontargeted metabolomics" 34 : 1-8, 2015
• 305 Waitz, J. A, "Biological activity of antibiotic G-418, a new micromonosporaproduced aminoglycoside with activity against protozoa and helminths" 6 : 579-581, 1974
• 306 Kurtböke, D, "Biodiscovery from rare actinomycetes:An eco-taxonomical perspective" 93 : 1843-1852, 2012
• 307 Genilloud, O., "Bergey’s Manual of Systematic Bacteriology - The Actinobacteria" Springer-Verlag 1039-1057, 2012
• 308 Belanger, A. E., "Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate" 40 : 1109-1109, 2005
• 309 Kim, Y. H., "Arisostatins A induces apoptosis through the activation of caspase-3 and reactive oxygen species generation in AMC-HN-4 cells" 309 : 449-456, 2003
• 310 Igarashi, Y., "Arisostatins A and B, new members of tetrocarcin class of antibiotics from Micromonospora sp. TPA0316- II. Structure determination" 53 : 233-240, 2000
• 311 Furumai, T., "Arisostatins A and B, new members of tetrocarcin class of antibiotics from Micromonospora sp. TP-A0316 - I. Taxonomy, fermentation, isolation and biological properties" 53 : 227-232, 2000
• 312 Kobinata, K., "Antlermicins B and C, new members of the antlermicin family" 33 : 772-775, 1980
• 313 Igarashi, Y, "Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov" 17 : 3702-3705, 2007
• 314 Abdelmohsen, U. R, "Antioxidant and anti-protease activities of diazepinomicin from the spongeassociated Micromonospora strain RV115" 10 : 2208-2221, 2012
• 315 Tansarli, G. S., "Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011)" 11 : 421-428, 2013
• 316 O’Neil, J., "Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations"
• 317 Nair, M. G., "Antifungal Anthracycline antibiotics, Spartanamicin-A and Spartanamicin-B from Micromonospora spp" 45 : 1738-1745, 1992
• 318 Martinez, J. L, "Antibiotics and antibiotic resistance genes in natural environments" 321 : 365-367, 2008
• 319 Doshi, P, "Antibiotics Speeding new antibiotics to market:A fake fix?" 350 : 2015
• 320 Weinstein, M. J., "Antibiotics 460 and methods for their production. US Patent 3,454,696"
• 321 Hansen, M. P., "Antibiotic resistance: What are the opportunities for primary care in alleviating the crisis?" 3 : 35-, 2015
• 322 Ilavsky, J, "Antibiotic from Micromonospora purpurea. US Patent 3,903,072"
• 323 Wagman, G. H., "Antibiotic from Micromonospora" 34 : 537-557, 1980
• 324 Donadio, S., "Antibiotic discovery in the twenty-first century: current trends and future perspectives" 63 : 423-430, 2010
• 325 Wagman, G. H, "Antibiotic G-418, a new Micromonospora-produced aminoglycoside with activity against protozoa and helminths:fermentation, isolation, and preliminary characterization" 6 : 144-149, 1974
• 326 Shimotohno, K. W., "Antibiotic AC6H, a new component of tetrocarcin group antibiotics" 46 : 682-686, 1993
• 327 Wagman, G. H., "Antibiotic 6640. II. Fermentation, isolation, and properties" 23 : 555-558, 1970
• 328 Waitz, J. A, "Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic" 23 : 559-565, 1970
• 329 Weinstein, M. J., "Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic" 23 : 551-554, 1970
• 330 Transparency Market Research, "Antibacterial drugs market (by class and pipeline analysis) - global industry analysis, size, share, growth, trends and forecast, 2013–2019 -market research report"
• 331 Phillips, I., "Antibacterial activity of netilmicin, a new aminoglycoside antibiotic, compared with that of gentamicin" 11 : 402-406, 1977
• 332 Miyanaga, S., "Anti-invasive and anti-angiogenic activities of naturally occurring dibenzodiazepine BU-4664L and its derivatives" 20 : 963-965, 2010
• 333 Yano, H, "Anti-hiv drug EP 0610519 A1. European Patent EP19940908806"
• 334 Sousa, S., "Anthracyclinones from Micromonospora sp" 75 : 489-493, 2012
• 335 Fehr, T, "Antascomicins A, B, C, D and E - Novel FKBP12 binding compounds from a Micromonospora strain" 49 : 230-233, 1996
• 336 Ganguly, A. K, "Annual Reports in Medicinal Chemistry - Volume 48" Academic Press 3-14, 2013
• 337 Beekes, M., "Analytical applications of Fourier transform-infrared (FT-IR) spectroscopy in microbiology and prion research" 123 : 305-319, 2007
• 338 Wright, G, "An irresistible newcomer" 517 : 442-444, 2015
• 339 Terahara, T., "An effective method based on wet-heat treatment for the selective isolation of Micromonospora from estuarine sediments" 29 : 1677-1684, 2013
• 340 Fisher, W. P, "An actinomycin from a species of the genus Micromonospora" 1 : 571-572, 1951
• 341 Jackson, J, "Aminoglycosides:how should we use them in the 21st century?" 26 : 516-525, 2013
• 342 Poulikakos, P., "Aminoglycoside therapy in infectious diseases" 14 : 1585-1597, 2013
• 343 Piepersberg, W., "Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery" Wiley-Interscience 15-118, 2007
• 344 Schultz, E., "A novel method for single bacteria identification by Raman spectroscopy" 89390D : 1-14, 2014
• 345 Iizaka, Y, "A new mycinosyl rosamicin derivative produced by an engineered Micromonospora rosaria mutant with a cytochrome P450 gene disruption introducing the D-mycinose biosynthetic gene" 41 : 1451-1456, 2014
• 346 Yoon, S. K., "A new compound from Micromonospora sp. SA246, 9-hydroxycrisamicin-A, activates hepatitis B virus replication" 319 : 859-865, 2004
• 347 Marquez, J. A., "A new broad spectrum aminoglycoside antibiotic, G-52, produced by Micromonospora zionensis" 29 : 483-487, 1976
• 348 Kobinata, K., "A new antibiotic, antlermicin A" 33 : 244-246, 1980
• 349 Ling, L. L, "A new antibiotic kills pathogens without detectable resistance" 517 : 455-459, 2015
• 350 Okachi, R., "A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties" 27 : 793-800, 1974
• 351 Yang, S. W, "A new anthracycline antibiotic micromonomycin from Micromonospora sp" 57 : 601-604, 2004
• 352 Wagman, G. H., "A new actinomycin complex produced by a Micromonospora species: Fermentation, isolation, and characterization" 9 : 465-469, 1976
• 353 Wagman, G. H., "A new Micromonospora-produced macrolide antibiotic, rosamicin" 25 : 641-646, 1972
• 354 Peng, F., "A new 20-membered macrolide produced by a marine-derived Micromonospora strain" 27 : 1366-1371, 2013
• 355 Yeo, W. H., "9-Hydroxycrisamicin A, a new cytotoxic isochromanquinone antibiotic produced by Micromonospora sp. SA246" 50 : 546-550, 1997
• 356 Hernandez, L. M., "4'-N-methyl-5'-hydroxystaurosporine and 5'-hydroxystaurosporine, new indolocarbazole alkaloids from a marine Micromonospora sp. strain" 53 : 895-902, 2000